James M. Inhofe sold CRSP

January 5, 2021 · STOCK Act disclosure

Senator James M. Inhofe (Republican-OK) sold CRISPR Therapeutics AG, a stock transaction, valued at $1,001 - $15,000. The trade took place on January 5, 2021 and was disclosed on January 15, 2021 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.